Amgen USA Inc Contracts with Department of Health and Human Services
Relationship Overview
Total Contract Value: $1,123,296,898
Contract Count: 4
Average Contract Size: $280.8M
Sole Source Rate: 0%
Small Business Rate: 0%
Spending by Sector
- R&D: $773.9M (1 contracts)
- Healthcare: $349.4M (3 contracts)
Contracts
- TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. — $773.9M
- IGF::OT::IGF TASK ORDER 1 UNDER RFP-12-100-SOL-00016 — $157.3M
- IGF::OT::IGF RTOR NUMBER: RTOR-CSF-0005 ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION — $154.4M
- IGF::OT::IGF FOR OTHER FUNCTIONS PROJECT: ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION (RTOR-CSF-0003) — $37.7M
Frequently Asked Questions
How many contracts does Amgen USA Inc have with Department of Health and Human Services?
Amgen USA Inc has 4 contracts with Department of Health and Human Services worth a combined $1.1B.
What is the average contract size between Amgen USA Inc and Department of Health and Human Services?
The average contract size is $280.8M.
What percentage of Amgen USA Inc's contracts with Department of Health and Human Services are sole-source?
0% of the contracts are sole-source awards.